Philip Wagenheim - Net Worth and Insider Trading

Philip Wagenheim Net Worth

The estimated net worth of Philip Wagenheim is at least $6 Million dollars as of 2024-05-15. Philip Wagenheim is the Director of Immunome Inc and owns about 397,397 shares of Immunome Inc (IMNM) stock worth over $6 Million. Details can be seen in Philip Wagenheim's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Philip Wagenheim has not made any transactions after 2021-05-24 and currently still holds the listed stock(s).

Transaction Summary of Philip Wagenheim

To

Philip Wagenheim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Philip Wagenheim owns 3 companies in total, including Immunome Inc (IMNM) , The One Group Hospitality Inc (STKS) , and Lihua International Inc (LIWA) .

Click here to see the complete history of Philip Wagenheim’s form 4 insider trades.

Insider Ownership Summary of Philip Wagenheim

Ticker Comapny Transaction Date Type of Owner
IMNM Immunome Inc 2021-05-24 director
STKS The One Group Hospitality Inc 2007-07-13 director & 10 percent owner & Secretary
LIWA Lihua International Inc 2007-07-13 director & 10 percent owner & Secretary

Philip Wagenheim Latest Holdings Summary

Philip Wagenheim currently owns a total of 1 stock. Philip Wagenheim owns 397,397 shares of Immunome Inc (IMNM) as of May 24, 2021, with a value of $6 Million.

Latest Holdings of Philip Wagenheim

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMNM Immunome Inc 2021-05-24 397,397 15.14 6,016,591

Holding Weightings of Philip Wagenheim


Philip Wagenheim Form 4 Trading Tracker

According to the SEC Form 4 filings, Philip Wagenheim has made a total of 1 transactions in Immunome Inc (IMNM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 13,500 shares on May 24, 2021, which cost Philip Wagenheim around $247,725.

Insider Trading History of Philip Wagenheim

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Philip Wagenheim Trading Performance

GuruFocus tracks the stock performance after each of Philip Wagenheim's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Philip Wagenheim is -24.64%. GuruFocus also compares Philip Wagenheim's trading performance to market benchmark return within the same time period. The performance of stocks bought by Philip Wagenheim within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Philip Wagenheim's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Philip Wagenheim

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.31
Relative Return to S&P 500(%) -9.96

Philip Wagenheim Ownership Network

Ownership Network List of Philip Wagenheim

No Data

Ownership Network Relation of Philip Wagenheim


Philip Wagenheim Owned Company Details

What does Immunome Inc do?

Who are the key executives at Immunome Inc?

Philip Wagenheim is the director of Immunome Inc. Other key executives at Immunome Inc include Chief Medical Officer Robert Lechleider , director & President and CEO Clay B Siegall , and director & other: See remarks Isaac Barchas .

Immunome Inc (IMNM) Insider Trades Summary

Over the past 18 months, Philip Wagenheim made no insider transaction in Immunome Inc (IMNM). Other recent insider transactions involving Immunome Inc (IMNM) include a net purchase of 169,204 shares made by Clay B Siegall , and a net purchase of 42,300 shares made by Bruce Turner .

In summary, during the past 3 months, insiders sold 0 shares of Immunome Inc (IMNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunome Inc (IMNM) were sold and 211,504 shares were bought by its insiders, resulting in a net purchase of 211,504 shares.

Immunome Inc (IMNM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunome Inc Insider Transactions

No Available Data

Philip Wagenheim Mailing Address

Above is the net worth, insider trading, and ownership report for Philip Wagenheim. You might contact Philip Wagenheim via mailing address: 712 Fifth Avenue, 49th Floor, New York Ny 10019.

Discussions on Philip Wagenheim

No discussions yet.